3.4 Hypertensive Crises & Vascular Emergencies

3.4 Hypertensive Crises & Vascular Emergencies

Hypertensive Emergencies vs. Urgencies

Acute, severe elevations in blood pressure (BP), generally defined as systolic BP >180 mmHg and/or diastolic BP >120 mmHg, represent significant clinical challenges. The critical distinction that dictates management is not the absolute BP value, but the presence of acute, ongoing target organ damage (TOD).

• Hypertensive Urgency: Severe BP elevation without evidence of acute target organ damage. Patients are often asymptomatic or present with non-specific symptoms like headache or anxiety. Management does not require intravenous medications or admission to an ICU. The goal is a gradual reduction in BP over 24 to 48 hours using oral antihypertensive agents (e.g., clonidine, captopril, amlodipine) to prevent cerebral ischemia from auto-regulatory shifts.
• Hypertensive Emergency: Severe BP elevation complicated by acute, progressive target organ damage. This is a life-threatening scenario requiring immediate admission to an intensive care unit and prompt, carefully titrated intravenous therapy to halt ongoing organ injury.

Manifestations of Target Organ Damage

The pathophysiology of a hypertensive emergency involves a failure of normal autoregulation, leading to endothelial damage, fibrinoid necrosis of arterioles, and subsequent organ ischemia. Manifestations include:

• Neurological: Hypertensive encephalopathy (altered mental status, seizures, papilledema), acute ischemic stroke, intracranial hemorrhage, and subarachnoid hemorrhage.
• Cardiovascular: Acute Coronary Syndromes (ACS), Acute Decompensated Heart Failure with pulmonary edema, and acute aortic dissection.
• Renal: Acute kidney injury (AKI) marked by rapidly rising serum creatinine, hematuria, and proteinuria.
• Microvascular: Microangiopathic hemolytic anemia (schistocytes on peripheral smear) and eclampsia in pregnant patients.

General Principles of BP Reduction

In most hypertensive emergencies, the fundamental rule is: Do not drop the blood pressure too fast. Chronic hypertension shifts the cerebral autoregulation curve to the right; a sudden, drastic normalization of BP can precipitate watershed cerebral ischemia or infarction. The general guideline is to reduce the mean arterial pressure (MAP) by no more than 20% to 25% in the first hour, followed by a gradual reduction to approximately 160/100 mmHg over the next 2 to 6 hours.

However, there are three major exceptions requiring rapid and aggressive BP lowering to normal or near-normal levels:

1. Acute Aortic Dissection: Rapidly lower systolic BP to 100-120 mmHg.
2. Acute Ischemic Stroke (if receiving thrombolytics): Keep BP <185/110 mmHg before giving tPA, and <180/105 mmHg for 24 hours after.
3. Spontaneous Intracerebral Hemorrhage: Goal systolic BP <140 mmHg to prevent hematoma expansion.

Hypertensive Emergencies and Preferred IV Agents Table

Pharmacology of Intravenous Antihypertensives

AGACNPs must be adept at utilizing titratable IV drips:

• Labetalol: A combined alpha-1 and non-selective beta-blocker. Excellent for stroke and general emergencies. Avoid in reactive airway disease and severe bradycardia.
• Nicardipine & Clevidipine: Dihydropyridine calcium channel blockers. They provide potent, easily titratable arterial vasodilation without significant negative inotropic effects.
• Nitroprusside: A potent arterial and venous dilator. Used less frequently now due to the risk of sudden profound hypotension and the risk of cyanide/thiocyanate toxicity, especially in patients with renal or hepatic impairment or with infusions lasting longer than 24-48 hours.
• Nitroglycerin: Primarily a venodilator at lower doses, reducing preload. Excellent for heart failure and ACS.

Acute Aortic Dissection

An aortic dissection is a catastrophic vascular emergency defined by a tear in the intimal layer of the aorta, allowing blood to enter the media and create a false lumen.

• Stanford Type A: Involves the ascending aorta. This is a surgical emergency due to the high risk of progression to cardiac tamponade, aortic regurgitation, and coronary occlusion.
• Stanford Type B: Involves only the descending aorta. Usually managed medically unless complications (organ malperfusion, rupture) occur.

Clinical Presentation: Patients typically present with sudden, severe "tearing" or "ripping" chest or back pain. A variation in pulse quality or a significant blood pressure discrepancy (>20 mmHg) between the arms is highly suspicious. Diagnosis: CT Angiography (CTA) of the chest, abdomen, and pelvis is the gold standard diagnostic test. Medical Management (Anti-impulse Therapy): The crucial initial step is controlling the heart rate and blood pressure to halt the progression of the tear. Heart rate control must precede blood pressure control. If vasodilators (like nitroprusside) are given before beta-blockade, the resulting reflex tachycardia will increase the sheer stress (dP/dt) on the aortic wall and worsen the dissection. Esmolol, a short-acting beta-blocker, is commonly used to lower HR <60 bpm, followed by vasodilators to achieve a systolic BP of 100-120 mmHg.

Acute Limb Ischemia

Peripheral Arterial Occlusion resulting in acute limb ischemia threatens limb viability. The classic presentation includes the "6 Ps": Pain (often the earliest symptom), Pallor, Pulselessness, Paresthesia, Paralysis (a late, ominous sign), and Poikilothermia (coolness). Immediate systemic anticoagulation with intravenous heparin is mandatory to prevent clot propagation, followed by urgent vascular surgery consultation for revascularization via embolectomy, catheter-directed thrombolysis, or bypass grafting. Time is of the essence; irreversible nerve and muscle damage occurs within hours.